Zobrazeno 1 - 10
of 446
pro vyhledávání: '"E, Kitas"'
Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes
As of June 10th 2020 about 7.2 million individuals have tested positive for, and more than 410,000 have died due to COVID-19. In this review we outline the pathophysiology that underpins the potential use of anti-rheumatic therapies for severe COVID-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::f1c59d58b59deb8d818a648e410cffbf
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3000153
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3000153
Background:People living with HIV (PLWH) are at high cardiovascular disease (CVD) risk. Traditional CVD risk scores do not accurately reflect their CVD risk. Noninvasive subclinical vascular damage (SVD) biomarkers are valid surrogates of CVD and abl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::6433d24559ed19f12b4a7b0fcbad94de
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3121214
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3121214
Background and Purpose: Atherosclerotic plaque tissue rupture is one of the leading causes of strokes. Early carotid plaque monitoring can help reduce cardiovascular morbidity and mortality. Manual ultrasound plaque classification and characterizatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::fa248ce8539e0687a57314b83283722f
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3071259
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3071259
Nocebo effects are noxious reactions to therapeutic interventions that occur because of negative expectations of the patient. In the past decade, neurobiological data have revealed specific neural pathways induced by nocebos (that is, interventions t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::7232f3459a713734c2737233a983dc31
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3122861
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3122861
Autor:
E. Kitas
Therapeutic approaches to fight Alzheimer's Disease include anti-A? peptide antibodies and secretase inhibitors or modulators and aim to either prevent or reduce amyloidosis. Secretase inhibitors are considered to reduce the de novo production of A?,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22b04a8843f247ab0261b1ded14bb78a
Publikováno v:
International Journal of Peptide and Protein Research. 43:146-153
The synthon for O-thiophosphotyrosine, Fmoc-Tyr[PS(OBzl)2]-OH (1c), was prepared in 63%;, yield from Fmoc-Tyr-OH by first transient protection as the tBuMe2Si-ester and phosphinylation with (BzlO)2PNiPr2/ tetrazole followed by oxidation of P(III) to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0785fa3550f42faa5a908751ef8dc071
https://doi.org/10.1111/j.1399-3011.1994.tb00515.x
https://doi.org/10.1111/j.1399-3011.1994.tb00515.x
Autor:
Atzeni, Fabiola1 (AUTHOR) atzenifabiola@hotmail.com, Bartoloni, Elena2 (AUTHOR) elena.bartolonibocci@unipg.it, Cacciapaglia, Fabio3,4 (AUTHOR) fabio.cacciapaglia79@gmail.com, Gremese, Elisa5,6 (AUTHOR) eli.gremese@gmail.com, Manfredi, Andreina7 (AUTHOR) andreina.manfredi@gmail.com, Piga, Matteo8 (AUTHOR) matteopiga@unica.it, Sakellariou, Garifallia9,10 (AUTHOR) filiciasak@gmail.com, Spinelli, Francesca Romana11 (AUTHOR) francescaromana.spinelli@uniroma1.it, Viapiana, Ombretta12 (AUTHOR) ombretta.viapiana@univr.it, Erre, Gian Luca13 (AUTHOR) glerre@uniss.it
Publikováno v:
Journal of Clinical Medicine. Nov2024, Vol. 13 Issue 22, p6693. 9p.
Autor:
Colaço, Mariana1,2,3 (AUTHOR) mariana.colaco@cnc.uc.pt, Cruz, Maria T.1,2,3 (AUTHOR) trosete@ff.uc.pt, Almeida, Luís Pereira de1,2,3 (AUTHOR) luispa@cnc.uc.pt, Borges, Olga1,2,3 (AUTHOR) olga@ci.uc.pt
Publikováno v:
Pharmaceutics. Oct2024, Vol. 16 Issue 10, p1308. 46p.